Abstract
Serum anti-Müllerian hormone concentrations vary significantly over time and this should be taken into account when tailoring treatment protocols for patients undergoing controlled ovarian hyperstimulation (COH). Compared with FSH, serum anti-Müllerian hormone may have greater discriminatory power because of its modest intrapatient variation and the larger interpatient variation. ©2011 by American Society for Reproductive Medicine.
| Original language | English |
|---|---|
| Pages (from-to) | 1185-1187 |
| Number of pages | 2 |
| Journal | Fertility and Sterility |
| Volume | 95 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Mar 2011 |
Keywords
- Anti-Müllerian hormone
- FSH
- ovarian stimulation protocol
- sample variation